Number of employees
40
Annual revenue
$400000
Bioinform editor Uduak Grace Thomas interviews Dr. Michael J. McManus about his plans for Integromics move into the next-generation sequence analysis market. Integromics Appoints Dr. Michael J. McManus as President & CEO Integromics, a market leader in IT solutions provision for life sciences in the areas of genomics and proteomics, today announces that it has selected Dr. Michael J. McManus as President & CEO. Dr. McManus will lead the company’s efforts to expand in the world market, with a particular focus on proteomics and on further developing Integromics’ activity in the US and Asian markets.